Skip to content

Core Laboratories CLB Production Enhancement — Goodwill Acquired

Similar metrics at other companies

Flowco Holdings Inc. logo
FLOCProduction Solutions — Goodwill Gross Acquired During Period
$55.56M
Flowco Holdings Inc. logo
FLOCProduction Solutions — Goodwill Acquired
$55.56M
Calumet, Inc. logo
CLMTPerformance Brands — Goodwill Acquired
$0
Worthington Enterprises logo
WORConsumer Products — Goodwill Acquired During Period Value
-$59.25K-103%
Nelnet logo
NNIAsset Generation and Management — Goodwill acquired during the period
$0
Cadre Holdings logo
CDREProducts — Goodwill Acquired
$50.44M

Other financials

Income statement

See full
Revenue$121.8M-1.4%
Operating income$1.9M-57.3%
Net income-$789.0K-412%
EPS (diluted)-$0.02

Balance sheet

See full
Cash & equivalents$22.8M+3.2%
Total debt$167.8M-6.8%
Total equity$268.9M+6.1%
Total assets$587.7M+0.3%

Cash flow

See full
Operating cash flow$4.0M-40.5%
CapEx$3.4M+23.8%
Free cash flow$517.0K-86.7%

Valuation

See full
Market cap$503.38M-13.5%
Enterprise value$648.4M-12.3%
P/E17.3×-3.4×
P/S-0.2×

Profitability

See full
Operating margin10.3%-0.2pp
Net margin5.5%+0.1pp
FCF margin4.3%-4.6pp

Returns & leverage

See full
Return on equity11.1%-0.4pp
Debt / equity0.6×-0.1×
Current ratio-0.2×

Where this comes from

Reported directly by Core Laboratories in its filing.

Tagged under the XBRL concept us-gaap:GoodwillAcquiredDuringPeriod.

The official record: Core Laboratories’s 10-K, filed March 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about Core Laboratories's production enhancement — goodwill acquired.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Core Laboratories's production enhancement — goodwill acquired?
Core Laboratories (CLB) reported production enhancement — goodwill acquired of $0 in Q4 2025.
What does production enhancement — goodwill acquired mean?
This metric measures the value of goodwill recognized specifically within the Production Enhancement segment resulting from new acquisitions completed during the reporting period. It serves as an indicator of inorganic growth activity and the capital deployed to expand the segment's market share or technological capabilities. Tracking this helps investors evaluate the company's strategy for scaling operations through external expansion versus organic development.